268 related articles for article (PubMed ID: 26823744)
1. CD44v6 down-regulation is an independent prognostic factor for poor outcome of colorectal carcinoma.
Wang L; Liu Q; Lin D; Lai M
Int J Clin Exp Pathol; 2015; 8(11):14283-93. PubMed ID: 26823744
[TBL] [Abstract][Full Text] [Related]
2. Nuclear aldehyde dehydrogenase 1A1 (ALDH1A1) expression is a favorable prognostic indicator in colorectal carcinoma.
Wang L; Lin D; Fu Y; Lai M
Pathol Res Pract; 2016 Sep; 212(9):791-9. PubMed ID: 27461829
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of GRP78 and GRP94 is involved in colorectal carcinogenesis.
Takahashi H; Wang JP; Zheng HC; Masuda S; Takano Y
Histol Histopathol; 2011 Jun; 26(6):663-71. PubMed ID: 21472681
[TBL] [Abstract][Full Text] [Related]
4. Systematic assessment of the prognostic impact of membranous CD44v6 protein expression in colorectal cancer.
Zlobec I; Günthert U; Tornillo L; Iezzi G; Baumhoer D; Terracciano L; Lugli A
Histopathology; 2009 Nov; 55(5):564-75. PubMed ID: 19912362
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the correlation of KAI1/CD82, CD44, MMP7 and β-catenin in the prediction of prognosis and metastasis in colorectal carcinoma.
Wu Q; Yang Y; Wu S; Li W; Zhang N; Dong X; Ou Y
Diagn Pathol; 2015 Sep; 10():176. PubMed ID: 26408312
[TBL] [Abstract][Full Text] [Related]
6. The clinicopathological significance of REIC expression in colorectal carcinomas.
Wang W; Zhu W; Xu XY; Nie XC; Yang X; Xing YN; Yu M; Liu YP; Takano Y; Zheng HC
Histol Histopathol; 2012 Jun; 27(6):735-43. PubMed ID: 22473694
[TBL] [Abstract][Full Text] [Related]
7. Characterization of cathepsin X in colorectal cancer development and progression.
Jechorek D; Votapek J; Meyer F; Kandulski A; Roessner A; Franke S
Pathol Res Pract; 2014 Dec; 210(12):822-9. PubMed ID: 25442015
[TBL] [Abstract][Full Text] [Related]
8. Morphological aspects of the hepatic response to neoadjuvant therapy.
Fernández-Aceñero MJ; Cortés-Guiral D; Muñoz LE; Martínez-Useros J; Pastor-Idoate C
Pathol Res Pract; 2015 Sep; 211(9):665-70. PubMed ID: 26163186
[TBL] [Abstract][Full Text] [Related]
9. Altered expression of fibroblast activation protein-α (FAP) in colorectal adenoma-carcinoma sequence and in lymph node and liver metastases.
Solano-Iturri JD; Beitia M; Errarte P; Calvete-Candenas J; Etxezarraga MC; Loizate A; Echevarria E; Badiola I; Larrinaga G
Aging (Albany NY); 2020 May; 12(11):10337-10358. PubMed ID: 32428869
[TBL] [Abstract][Full Text] [Related]
10. CD44v6 expression in patients with stage II or stage III sporadic colorectal cancer is superior to CD44 expression for predicting progression.
Zhao LH; Lin QL; Wei J; Huai YL; Wang KJ; Yan HY
Int J Clin Exp Pathol; 2015; 8(1):692-701. PubMed ID: 25755763
[TBL] [Abstract][Full Text] [Related]
11. Linear quantification of lymphoid infiltration of the tumor margin: a reproducible method, developed with colorectal cancer tissues, for assessing a highly variable prognostic factor.
Allard MA; Bachet JB; Beauchet A; Julie C; Malafosse R; Penna C; Nordlinger B; Emile JF
Diagn Pathol; 2012 Nov; 7():156. PubMed ID: 23148481
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of PAK-1 is an independent predictor of disease recurrence in colorectal carcinoma.
Al-Maghrabi J; Emam E; Gomaa W; Al-Qaydy D; Al-Maghrabi B; Buhmeida A; Abuzenadah A; Al-Qahtani M; Al-Ahwal M
Int J Clin Exp Pathol; 2015; 8(12):15895-902. PubMed ID: 26884861
[TBL] [Abstract][Full Text] [Related]
13. CD44V6 expression in human colorectal carcinoma.
Coppola D; Hyacinthe M; Fu L; Cantor AB; Karl R; Marcet J; Cooper DL; Nicosia SV; Cooper HS
Hum Pathol; 1998 Jun; 29(6):627-35. PubMed ID: 9635685
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of the microRNA processing enzyme Dicer is a prognostic factor in human colorectal cancer.
Faggad A; Kasajima A; Weichert W; Stenzinger A; Elwali NE; Dietel M; Denkert C
Histopathology; 2012 Oct; 61(4):552-61. PubMed ID: 22716222
[TBL] [Abstract][Full Text] [Related]
15. Soluble CD44 variant 6 as a prognostic indicator in patients with colorectal cancer.
Yamane N; Tsujitani S; Makino M; Maeta M; Kaibara N
Oncology; 1999 Apr; 56(3):232-8. PubMed ID: 10202279
[TBL] [Abstract][Full Text] [Related]
16. The expression of CD44v6 in colon: from normal to malignant.
Afify A; Durbin-Johnson B; Virdi A; Jess H
Ann Diagn Pathol; 2016 Feb; 20():19-23. PubMed ID: 26621455
[TBL] [Abstract][Full Text] [Related]
17. CYP24A1 is a potential biomarker for the progression and prognosis of human colorectal cancer.
Sun H; Wang C; Hao M; Sun R; Wang Y; Liu T; Cong X; Liu Y
Hum Pathol; 2016 Apr; 50():101-8. PubMed ID: 26997443
[TBL] [Abstract][Full Text] [Related]
18. Keratin 7 expression in lymph node metastases but not in the primary tumour correlates with distant metastases and poor prognosis in colon carcinoma.
Czapiewski P; Bobowicz M; Pęksa R; Skrzypski M; Gorczyński A; Szczepańska-Michalska K; Korwat A; Jankowski M; Zegarski W; Szulgo-Paczkowska A; Polec T; Piątek M; Skokowski J; Haybaeck J; Żaczek A; Biernat W
Pol J Pathol; 2016; 67(3):228-234. PubMed ID: 28155971
[TBL] [Abstract][Full Text] [Related]
19. Reduced expression of EphB2 that parallels invasion and metastasis in colorectal tumours.
Guo DL; Zhang J; Yuen ST; Tsui WY; Chan AS; Ho C; Ji J; Leung SY; Chen X
Carcinogenesis; 2006 Mar; 27(3):454-64. PubMed ID: 16272170
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic features of synchronous colorectal carcinoma: A distinct subset arising from multiple sessile serrated adenomas and associated with high levels of microsatellite instability and favorable prognosis.
Hu H; Chang DT; Nikiforova MN; Kuan SF; Pai RK
Am J Surg Pathol; 2013 Nov; 37(11):1660-70. PubMed ID: 23887157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]